C21 Investments Inc. (CXXIF)
C21 Investments Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.27, up 0.11% on the session, giving a market capitalisation of $32.0M. On trailing twelve-month figures it carries a trailing P/E of -12.61, a net margin of -9.9%. Its beta of 1.88 implies it has historically moved more than the broad market.
C21 Investments Inc. operates as a fully integrated cannabis enterprise, overseeing the cultivation, processing, distribution, and retail sale of cannabis and hemp-derived consumer goods throughout the United States. Its diverse product line features pre-packaged and bulk flower, vape cartridges, concentrated extracts, ingestible items, pre-rolled joints, liquid tinctures, and topical applications. Beyond its core cannabis business, the company also provides payroll and benefits administration services. Founded in 1987, C21 Investments Inc. maintains its corporate headquarters in Vancouver, Canada. The company was formerly known as Curlew Lake Resources Inc. until it adopted its current name in November 2017.
C21 Investments Inc. is most often compared with the following Healthcare names: